Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Gabbert

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Cell and Tissue Research|May 1, 1990
Crystalloid lysozyme inclusions in Paneth cells of vitamin A-deficient ratsM J Koch, H K Biesalski, E Stofft, et al.
British Journal of Cancer|February 1, 1996
Growth inhibition in clonal subpopulations of a human epithelioid sarcoma cell line by retinoic acid and tumour necrosis factor alphaR Engers, F van Roy, T Heymer, et al.
British Journal of Cancer|March 5, 2002
Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progressionA Krieg, C Mahotka, T Krieg, et al.
Journal of Cancer Research and Clinical Oncology|May 29, 2007
Microsatellite instability in Ewing tumor is not associated with loss of mismatch repair protein expressionI Alldinger, K L Schaefer, D Goedde, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 2000
Resistance to CD95 (APO-1/Fas)-mediated apoptosis in human renal cell carcinomas: an important factor for evasion from negative growth controlC D Gerharz, U Ramp, M Déjosez, et al.
British Journal of Cancer|June 6, 2000
Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinomaU Ramp, M Dejosez, C Mahotka, et al.
The American Journal of Pathology|December 14, 1999
Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibodyK F Becker, E Kremmer, M Eulitz, et al.
European Radiology|February 28, 2016
Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required?L Schimmöller, M Quentin, D Blondin, et al.
British Journal of Cancer|August 26, 2004
Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomasY Yan, C Mahotka, S Heikaus, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2008
Interobserver reproducibility of Gleason grading: evaluation using prostate cancer tissue microarraysM Burchardt, R Engers, M Müller, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Cell and Tissue Research|May 1, 1990
Crystalloid lysozyme inclusions in Paneth cells of vitamin A-deficient ratsM J Koch, H K Biesalski, E Stofft, et al.
British Journal of Cancer|February 1, 1996
Growth inhibition in clonal subpopulations of a human epithelioid sarcoma cell line by retinoic acid and tumour necrosis factor alphaR Engers, F van Roy, T Heymer, et al.
British Journal of Cancer|March 5, 2002
Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progressionA Krieg, C Mahotka, T Krieg, et al.
Journal of Cancer Research and Clinical Oncology|May 29, 2007
Microsatellite instability in Ewing tumor is not associated with loss of mismatch repair protein expressionI Alldinger, K L Schaefer, D Goedde, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 2000
Resistance to CD95 (APO-1/Fas)-mediated apoptosis in human renal cell carcinomas: an important factor for evasion from negative growth controlC D Gerharz, U Ramp, M Déjosez, et al.
British Journal of Cancer|June 6, 2000
Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinomaU Ramp, M Dejosez, C Mahotka, et al.
The American Journal of Pathology|December 14, 1999
Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibodyK F Becker, E Kremmer, M Eulitz, et al.
European Radiology|February 28, 2016
Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required?L Schimmöller, M Quentin, D Blondin, et al.
British Journal of Cancer|August 26, 2004
Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomasY Yan, C Mahotka, S Heikaus, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2008
Interobserver reproducibility of Gleason grading: evaluation using prostate cancer tissue microarraysM Burchardt, R Engers, M Müller, et al.
Pageof 14